Mint Dove (@mint_dove) header
Mint Dove (@mint_dove) profile picture
Joined November 2025
Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)Photo by Mint Dove (@mint_dove)
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson
641
16,091
727
33,307
2,895,166
No gangstawkin allowed 😤
2
3
103
Replying to @713Xtr0py
@713Xtr0py Going to reclaim Jerusalem for the Christians.
2
1
19
Replying to @BrightInsight6
Seems suspicious 🤔🤨🧐💭
13
23
5
512
17,077
GM Rolling up after work to like the posts
3
1
9
103
Patty cake?
1
1
3
63
Mint Dove retweeted
Replying to @713Xtr0py
@713Xtr0py I've been out of range for a while. My cousin took us to visit the ruins. Digging for family history.
1
1
1
16
Mint Dove retweeted
I get that. Now that Thanksmas and Epiphany are behind us, I am visiting my cousin in Kamchatka. Он забрал меня на автономном беспилотном транспортном средстве. Мы путешествуем по святым местам Сибири.
1
1
2
47
How was Langley??
Replying to @713Xtr0py
@713Xtr0py As the final chimes of 2025 echo, we must ever hone our art—juggling time itself with graceful precision, ever poised for the wonders of 2026. 🐰📷Happy New Year, dear friends. May your days ahead be as elegantly balanced.
1
24
Mint Dove retweeted
Replying to @713Xtr0py
@713Xtr0py Today we celebrate by running circles around the totem, driving a path in the snow, faster and faster, until time itself blurs into a halo soaring up into the aether. We fall back to earth exhausted, satisfied our duty is done, ready to repeat the holy ritual next year
1
1
31
Mint Dove retweeted
Replying to @713Xtr0py
@713Xtr0py It is our custom on the 19th of December to bring garlands of Thanksmas decorations into the field and decorate the yaks while singing spiritual songs by the creek. This ancient Tibetan custom brings glad tidings for the New Year and dissipates all bad karma.
1
1
23